| Emily Suzann Slaughterbeck, CNM | |
|
101 Manning Dr, Chapel Hill, NC 27514-4220 | |
| (984) 974-1000 | |
| Not Available |
| Full Name | Emily Suzann Slaughterbeck |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 101 Manning Dr, Chapel Hill, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407249196 | NPI | - | NPPES |
| 1407249196 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | (* (Not Available)) | Primary |
| Entity Name | University Of North Carolina At Chapel Hill |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
New findings explaining the complicated process by which the "energy substations" of human cells split apart and recombine may lay the groundwork for new treatment approaches to a wide range of diseases, including some cancers and neurodegenerative diseases such as Parkinson's and Alzheimer's.
With the establishment of five new Clinical Research Units the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) hopes to give a further boost to clinical research in Germany and drive progress in the scientific investigation and possibilities for the treatment of disease.
ARIAD Pharmaceuticals, Inc. today announced long-term results of the Phase 1 study of its investigational pan-BCR-ABL inhibitor, ponatinib, in heavily pretreated patients with resistant and refractory chronic myeloid leukemia (CML) and Philadelphia-positive acute lymphoblastic leukemia.
› Verified 8 days ago
| Entity Name | Uwh Of The Carolinas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639506470 PECOS PAC ID: 0042448169 Enrollment ID: O20140118000107 |
News Archive
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
New findings explaining the complicated process by which the "energy substations" of human cells split apart and recombine may lay the groundwork for new treatment approaches to a wide range of diseases, including some cancers and neurodegenerative diseases such as Parkinson's and Alzheimer's.
With the establishment of five new Clinical Research Units the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) hopes to give a further boost to clinical research in Germany and drive progress in the scientific investigation and possibilities for the treatment of disease.
ARIAD Pharmaceuticals, Inc. today announced long-term results of the Phase 1 study of its investigational pan-BCR-ABL inhibitor, ponatinib, in heavily pretreated patients with resistant and refractory chronic myeloid leukemia (CML) and Philadelphia-positive acute lymphoblastic leukemia.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Suzann Slaughterbeck, CNM 3200 Northline Ave Ste 130, Greensboro, NC 27408-7600 Ph: (336) 286-6565 | Emily Suzann Slaughterbeck, CNM 101 Manning Dr, Chapel Hill, NC 27514-4220 Ph: (984) 974-1000 |
News Archive
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
New findings explaining the complicated process by which the "energy substations" of human cells split apart and recombine may lay the groundwork for new treatment approaches to a wide range of diseases, including some cancers and neurodegenerative diseases such as Parkinson's and Alzheimer's.
With the establishment of five new Clinical Research Units the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) hopes to give a further boost to clinical research in Germany and drive progress in the scientific investigation and possibilities for the treatment of disease.
ARIAD Pharmaceuticals, Inc. today announced long-term results of the Phase 1 study of its investigational pan-BCR-ABL inhibitor, ponatinib, in heavily pretreated patients with resistant and refractory chronic myeloid leukemia (CML) and Philadelphia-positive acute lymphoblastic leukemia.
› Verified 8 days ago
Ana Debora Turaga, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 984-974-2131 | |
Jane A Arnold, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 101 Manning Dr, Chapel Hill, NC 27599 Phone: 919-966-4996 Fax: 919-843-5515 | |
Amanda Mary Brown, CNM, MPH Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 984-974-3422 | |
Karen Sheffield-abdullah, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 919-966-6049 | |
Shannon L Maaske, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 4011 Old Clinic Bldg Cb#7570, Chapel Hill, NC 27599 Phone: 919-843-2490 Fax: 919-843-6938 | |
Mrs. Mariah Prete Velazquez, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 930 Martin Luther King Jr Blvd, Suite 202, Chapel Hill, NC 27514 Phone: 919-933-3301 | |
Jenkins Michelle Lawhorn, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 984-974-1000 |